Impact Biomedical (IBO) FCF Margin (2023 - 2026)
Impact Biomedical's FCF Margin came in at 52.38% for Q3 2026, up 3457.94 percentage points from -3405.56% a year earlier but down 15614.29 percentage points from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) FCF Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Impact Biomedical reported FCF Margin of 305.26%, up 2645171192.36 percentage points year-over-year; for FY2025, it was -5906.25%, up 16047.60 percentage points from FY2024.
- FCF Margin carries a three-year change of -870.25 percentage points (FY2022 to FY2025).
- Going back by year, FCF Margin was -21953.85% in FY2024 (+115.38 pp), -22069.23% in FY2023 (-17033.23 pp) and -5036.00% in FY2022.
- The five-year range for quarterly FCF Margin is -11714283914.29% (Q2 2025) to 15666.67% (Q2 2026).
- Year-over-year, FCF Margin has increased for five consecutive quarters, with an average year-over-year change of +10900.60 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q2 2026 (a gain of 11714299580.95 percentage points), and the weakest in Q2 2025 (a drop of 11714271080.95 percentage points).
- Business Quant data shows IBO's FCF Margin at 15666.67% (Q2 2026), -6628.57% (Q1 2026) and 1414.29% (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 28.96% |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 52.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 52.38% |
| Jun 30, 2026 | 15,666.67% |
| Mar 31, 2026 | -6,628.57% |
| Dec 31, 2025 | 1,414.29% |
| Sep 30, 2025 | -3,405.56% |
| Jun 30, 2025 | -11,714,283,914.29% |
| Mar 31, 2025 | -50,066.67% |
| Dec 31, 2024 | -32,866.67% |
| Sep 30, 2024 | -33,366.67% |
| Jun 30, 2024 | -12,833.33% |
| Mar 31, 2024 | -16,066.67% |
| Dec 31, 2023 | -14,433.33% |
| Sep 30, 2023 | -22,400.00% |
API Access
Impact Biomedical FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();